申请人:HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LIMITED
公开号:US20150073003A1
公开(公告)日:2015-03-12
The present invention provides new ceramide analogs indicated as the compounds of formula (II). These novel analogs exhibit a significant anti cancerous effect and are therefore provided as a pharmaceutical composition for treating cell proliferative diseases, neurodegenerative disorders, metabolism-associated conditions, infectious diseases, and immune-related disorders. The invention further provides combined compositions and kits combining the novel ceramide analogs of formula (II) with an additional therapeutic agent.
本发明提供了新的神经酰胺类似物,其被指定为公式(II)化合物。这些新颖的类似物表现出显著的抗癌作用,因此作为治疗细胞增殖性疾病、神经退行性疾病、与代谢相关的疾病、感染性疾病和免疫相关疾病的药物组合物而提供。本发明还提供了将公式(II)的新的神经酰胺类似物与其他治疗剂组合的组合物和套件。